Inmed pharmaceuticals announces closing of us$12 million private placement priced at-the-market under nasdaq rules

Vancouver, british columbia, july 02, 2021 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq: inm), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates as well as manufacturing technologies for pharmaceutical-grade rare cannabinoids, today announced that it has closed the previously announced private placement.
INM Ratings Summary
INM Quant Ranking